RHB-104 in CD

Print

Details of Research

Contact: Shelley Mikolainis, Research Coordinator
416-586-4800 ext 4989
smikolainis@mtsinai.on.ca

Primary Investigator: Dr. Hillary Steinhart

Enrolment: Ongoing

Expectation: 9/14 visits require the patient to stay for 3 hours for PK testing

Eligibility

  • Clarithromycin, Rifabutin, Clofazimine vs placebo
  • Currently on at least one of the following: 5-ASA, steroids, immunosuppressants, infliximab or adalimumab
  • One of the following: increased CRP, increased fecal calprotectin or active CD on CO/MRE/CTE within last 5 weeks


Exclusions
: active or healed fistula within last 2 months, on meds that prolong QT interval or are a CYP3A4 substrate, oral/IV antibiotcs or probiotics within 4 weeks to BL, history or current uveitis

WE INVITE YOU TO PARTNER WITH US TODAY
Donate to the Zane Cohen Centre
Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex. Copyright © 1997 - 2014.
All Rights Reserved. A patient care, teaching and research centre affiliated with University of Toronto.
Powered by Joomla 1.7 Templates